REGN

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Regeneron Pharmaceuticals (REGN) Earnings Date & Reports

Industry: @Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

REGN is expected to report earnings to fall 9.71% to $11.25 per share on January 31

Regeneron Pharmaceuticals REGN Stock Earnings Reports

Q4'24

Est.

$11.25

Q3'24

Beat

by $0.74

Q2'24

Beat

by $0.95

Q1'24

Missed

by $0.64

Q4'23

Beat

by $1.09

The last earnings report on October 31 showed earnings per share of $12.46, beating the estimate of $11.72. With 222.51K shares outstanding, the current market capitalization sits at 81.32B.

View a ticker or compare two or three

Compare

REGN

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For REGN
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for REGN (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a developer of medicines for the treatment of serious medical conditions

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

777 Old Saw Mill River Road

Phone

+1 914 847-7000

Employees

13450

Web

https://www.regeneron.com